Research Webinar: Update on Rozanolixizumab

Academic Research in Myasthenia Gravis: From Securing Funding to Reporting New FindingsПодробнее

Research Webinar - Kickoff with Dr. Jeff GuptilПодробнее

Efficacy and Safety of Rozanolixizumab to Treat Myasthenia GravisПодробнее

Research Webinar Series: New Treatment for Generalized Myasthenia GravisПодробнее

UCB Announces Phase 3 Results for Zilucoplan and Rozanolixizumab in Generalized Myasthenia Gravis (gПодробнее

Research Webinar: Adverse Event Unit ProjectПодробнее

cosMOG: anti-FcRn agent rozanolixizumab for relapse prevention in MOGADПодробнее

Clinical Trial: Rozanolixizumab for MOG Antibody-associated Disease (NCT05063162)Подробнее

2022 in Review – Research UpdateПодробнее

Understanding Clinical Trials for MOGAD & the Importance of Patient ParticipationПодробнее

Research Updates in Myasthenia GravisПодробнее

#LetsTalkNMD - Myasthenia Gravis: Clinical and Research UpdatesПодробнее

Updates and Research and Clinical Trials for MGПодробнее

MGFA Webinar Series: MG Drugs in DevelopmentПодробнее

Myositis Research Webinar with Dr Helene Alexanderson May 2023Подробнее

Two Different Approaches in the Treatment of gMG.Подробнее